GLAXOSMITHKLINE PLC's ticker is GSK and the CUSIP is 37733W105. A total of 789 filers reported holding GLAXOSMITHKLINE PLC in Q3 2018. The put-call ratio across all filers is 0.82 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2022 | $179,000 | +7.8% | 4,116 | +7.8% | 0.01% | +25.0% |
Q1 2022 | $166,000 | -1.2% | 3,817 | 0.0% | 0.00% | 0.0% |
Q4 2021 | $168,000 | +15.1% | 3,817 | 0.0% | 0.00% | 0.0% |
Q3 2021 | $146,000 | -18.9% | 3,817 | -15.7% | 0.00% | 0.0% |
Q2 2021 | $180,000 | +10.4% | 4,527 | -1.1% | 0.00% | 0.0% |
Q1 2021 | $163,000 | -8.9% | 4,577 | -6.2% | 0.00% | -20.0% |
Q4 2020 | $179,000 | -7.3% | 4,877 | -5.1% | 0.01% | -16.7% |
Q3 2020 | $193,000 | +4.3% | 5,137 | +13.5% | 0.01% | 0.0% |
Q2 2020 | $185,000 | -14.7% | 4,527 | -21.1% | 0.01% | -33.3% |
Q1 2020 | $217,000 | +14.2% | 5,739 | +41.6% | 0.01% | +50.0% |
Q4 2019 | $190,000 | +12.4% | 4,052 | +2.5% | 0.01% | 0.0% |
Q3 2019 | $169,000 | +23.4% | 3,952 | +15.7% | 0.01% | +20.0% |
Q2 2019 | $137,000 | -42.2% | 3,417 | -42.0% | 0.01% | -54.5% |
Q3 2018 | $237,000 | 0.0% | 5,890 | 0.0% | 0.01% | +10.0% |
Q2 2018 | $237,000 | +3.0% | 5,890 | 0.0% | 0.01% | +11.1% |
Q1 2018 | $230,000 | +9.5% | 5,890 | -0.7% | 0.01% | +12.5% |
Q4 2017 | $210,000 | -12.1% | 5,934 | +0.7% | 0.01% | -20.0% |
Q3 2017 | $239,000 | -13.4% | 5,890 | -7.9% | 0.01% | -16.7% |
Q2 2017 | $276,000 | -0.7% | 6,392 | -3.0% | 0.01% | -7.7% |
Q1 2017 | $278,000 | +18.3% | 6,592 | +8.2% | 0.01% | +18.2% |
Q4 2016 | $235,000 | -10.6% | 6,090 | 0.0% | 0.01% | -15.4% |
Q3 2016 | $263,000 | -22.0% | 6,090 | -21.6% | 0.01% | -23.5% |
Q2 2016 | $337,000 | -6.4% | 7,770 | -12.3% | 0.02% | -10.5% |
Q1 2016 | $360,000 | -22.6% | 8,863 | -23.1% | 0.02% | -20.8% |
Q4 2015 | $465,000 | +7.1% | 11,531 | +2.2% | 0.02% | 0.0% |
Q3 2015 | $434,000 | -9.6% | 11,286 | -2.0% | 0.02% | 0.0% |
Q2 2015 | $480,000 | -9.8% | 11,517 | 0.0% | 0.02% | -11.1% |
Q1 2015 | $532,000 | +6.0% | 11,517 | -2.0% | 0.03% | +8.0% |
Q4 2014 | $502,000 | -1.0% | 11,752 | +6.5% | 0.02% | -3.8% |
Q3 2014 | $507,000 | -21.3% | 11,034 | -8.4% | 0.03% | -21.2% |
Q2 2014 | $644,000 | -2.4% | 12,046 | -2.5% | 0.03% | -5.7% |
Q1 2014 | $660,000 | +13.2% | 12,361 | +13.1% | 0.04% | +12.9% |
Q4 2013 | $583,000 | +4.5% | 10,926 | -1.8% | 0.03% | -3.1% |
Q3 2013 | $558,000 | +0.4% | 11,126 | 0.0% | 0.03% | -3.0% |
Q2 2013 | $556,000 | – | 11,126 | – | 0.03% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
OSTERWEIS CAPITAL MANAGEMENT INC | 1,948,915 | $79,029,000 | 4.59% |
Chubb Ltd | 400,000 | $16,220,000 | 4.42% |
Pegasus Partners Ltd. | 172,275 | $6,986,000 | 3.79% |
Keystone Financial Planning, Inc. | 117,762 | $4,775,000 | 3.42% |
P.R. Herzig & Co. Inc. | 36,950 | $1,498,000 | 3.28% |
Sterneck Capital Management, LLC | 112,535 | $4,563,000 | 3.21% |
Healthcare Value Capital, LLC | 50,000 | $2,028,000 | 2.98% |
Hamlin Capital Management, LLC | 1,454,031 | $58,961,000 | 2.98% |
Jolley Asset Management, LLC | 80,639 | $3,270,000 | 2.98% |
JFB Holdings Corp | 2,415,570 | $97,951,000 | 2.91% |